The going rate on shrinks: Big Pharma and the buying of psychiatry. (Gazette).
American Prospect, The, July, 2002 by Torrey, E. Fuller
IT WAS LAST SUMMER IN BERLIN when I first encountered pharmaceutical funhouses. I was one of 4,000 attendees at the 7th World Congress of Biological Psychiatry. Until about a decade ago, pharmaceutical companies passed out pens or notepads with their companies' logos at such events, and most speakers presented data and opinions based upon their true scientific beliefs.
That all changed when Big Pharma took over. At the congress, I counted 15 major displays on the way to the lunch area, including an artificial garden (Janssen-Cilag), a brook running over stones (Lundbeck), and ...
Read the rest of this article with a Free Trial at HighBeam Research.